Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Convalescent plasma Emergency use authorization Experimental Antiviral May/16/2022 43 10
Ivermectin Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/30/2022 17 3
Ritonavir Emergency use authorization Used to treat other disease Antiviral Nov/02/2021 27 14
Chloroquine phosphate Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/27/2021 25 9
Menadione Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/24/2021 2 0
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/22/2021 26 15
Heparin Potential treatment - clinical evidence Used to treat other disease Antiviral Jan/22/2021 12 1
Sofosbuvir Potential treatment - clinical evidence Used to treat other disease Antiviral Dec/18/2020 6 5
Interferon beta-1a Potential treatment - clinical evidence Used to treat other disease Other treatment Nov/12/2020 2 1
Auranofin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral May/29/2020 2 0
Excel (.xslx) CSV (.csv)